Trial results
AI generated results summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
According to the results reported on ClinicalTrials.gov, this trial enrolled 157 people who visited an emergency department — 79 received a fluid drip called Lactated Ringer's Solution and 78 received Normal Saline Solution (a standard salt-water drip). The trial was measuring how well patients felt they had recovered after receiving one of these two fluids, using a questionnaire called the Quality of Recovery-40 (QoR-40). This is a self-reported survey with 40 questions where patients rate how they are feeling across a range of areas; scores run from 40 (poorest recovery) to 200 (best recovery). Not everyone completed the study — 41 people in the Lactated Ringer's group and 53 in the Normal Saline group finished. The reported data shows that 24 hours after treatment, the average QoR-40 score for the Lactated Ringer's group was 166.8 out of 200, and for the Normal Saline group it was 164.4 out of 200. At an earlier time point — shortly after the fluid was given — the reported average scores were 152.6 for the Lactated Ringer's group and 141.6 for the Normal Saline group. These numbers reflect how patients rated their own recovery at those two points in time. The reported data also shows some follow-up information collected seven days later via text message. In the Lactated Ringer's group, 14 participants reported filling a prescription from the emergency department, 5 reported returning to the emergency department for the same problem, and 9 reported seeing another health provider for the same complaint. In the Normal Saline group, those numbers were 19, 7, and 7 respectively. These are the results as reported to ClinicalTrials.gov. They are not medical advice — always discuss what they mean for you with your doctor.
View full results on ClinicalTrials.gov ↗ · Read the linked publication on PubMed (PMID 30146446) ↗
These are the results as reported to ClinicalTrials.gov, not medical advice. Verify independently with the trial site and discuss what they mean for you with your doctor.
Phase 4 Uveitis Trial, Completed
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are being seen in an emergency department (ER)
- Your main reason for visiting the ER is nausea, vomiting, diarrhea, stomach pain, dehydration, heat stroke, or heat exhaustion
- The ER doctor has agreed that you can receive two liters of fluid (through a drip/IV)
- The ER doctor expects that you will be able to go home after your visit
- You have seen your regular family doctor or primary care doctor at least once in the last two years
- You have access to a phone for the two days after you leave the ER
Who may not be able to join:
- You are currently in prison or jail
- You are under 18 years old (confirm with trial site)
- You are known to be pregnant
- You have yellowing of the skin or eyes (jaundice)
- You are currently receiving chemotherapy (cancer treatment)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Quality of Recovery-40 Score at 24 Hours
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.